Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
12-2003 | 09-2003 | 06-2003 | 03-2003 | 12-2002 | |
Sales | 6,683 | 5,341 | 5,100 | 6,808 | 5,620 |
Cost of Goods | 2,125 | 1,411 | 1,222 | 2,142 | 2,088 |
Gross Profit | 4,558 | 3,930 | 3,878 | 4,666 | 3,532 |
Operating Expenses | 6,920 | 7,221 | 7,546 | 8,126 | 8,350 |
Operating Income | -2,237 | -2,880 | -3,446 | -3,318 | -4,730 |
Other Income | 270 | 119 | 261 | 278 | 291 |
Pre-tax Income | -1,967 | -2,761 | -3,185 | -3,040 | -4,439 |
Net Income Continuous | -1,967 | -2,761 | -3,185 | -3,040 | -4,439 |
Net Income | $-1,967 | $-2,761 | $-3,185 | $-3,040 | $-4,439 |
EPS Basic Total Ops | -0.09 | -0.13 | -0.15 | -0.15 | -0.21 |
EPS Basic Continuous Ops | -0.09 | -0.13 | -0.15 | -0.14 | -0.21 |
EPS Diluted Total Ops | -0.09 | -0.13 | -0.15 | -0.15 | -0.21 |
EPS Diluted Continuous Ops | -0.09 | -0.13 | -0.15 | -0.14 | -0.21 |
EBITDA(a) | $-1,890 | $-2,530 | $-3,087 | $-2,939 | $-4,397 |